Matthew A. Powell
马修·鲍威尔
MD
Professor and Division Chief, Gynecologic Oncology妇科肿瘤科教授兼科室主任
👥Biography 个人简介
Dr. Matthew Powell at Washington University/Siteman Cancer Center is a prominent gynecologic oncologist who leads NRG Oncology clinical trials in endometrial and ovarian cancer. He has advanced chemotherapy regimens, molecular stratification, and immunotherapy trials across multiple gynecologic malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
NRG Oncology Clinical Trials Leadership
Led multiple NRG Oncology phase III trials evaluating chemotherapy regimens and targeted agents in endometrial and ovarian cancers, establishing new evidence-based treatment standards.
Endometrial Cancer Staging and Treatment
Contributed to revisions in endometrial cancer staging and incorporated molecular markers into risk stratification, improving adjuvant therapy decision-making.
Representative Works 代表性著作
Paclitaxel and Carboplatin versus Paclitaxel and Ifosfamide in Endometrial Cancer (GOG 209)
Journal of Clinical Oncology (2022)
Established carboplatin-paclitaxel as equivalent to ifosfamide-paclitaxel with better tolerability in advanced endometrial cancer.
Molecular Stratification in Endometrial Cancer Clinical Trials
Gynecologic Oncology (2021)
Demonstrated incorporation of POLE and MMR status into trial design improves treatment selection for endometrial cancer patients.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Bradley J. Monk
University of Arizona / HonorHealth
Kathleen N. Moore
Stephenson Cancer Center, University of Oklahoma
Ana Oaknin
Vall d'Hebron University Hospital
Shannon Neville Westin
The University of Texas MD Anderson Cancer Center
关注 马修·鲍威尔 的研究动态
Follow Matthew A. Powell's research updates
留下邮箱，当我们发布与 Matthew A. Powell（Washington University School of Medicine / Siteman Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment